Cite

    Peres Valgas da Silva, C. et al. (2021). The effects of mirabegron on obesity‐induced inflammation and insulin resistance are associated with brown adipose tissue activation but not beiging in the subcutaneous white adipose tissue. Clinical and experimental pharmacology and physiology. pp. 1477-1487. [Online].